206 related articles for article (PubMed ID: 18513687)
1. Effects of percutaneous ethanol injection therapy on subsequent parathyroidectomy.
Chen HH; Hsu MT; Wu CJ; Chen YW; Yang TL
Am J Surg; 2008 Aug; 196(2):155-9. PubMed ID: 18513687
[TBL] [Abstract][Full Text] [Related]
2. [PEIT is the part of strategy for severe hyperparathyroidism in patients requiring hemodialysis].
Uemura K; Kakuta T
Clin Calcium; 2004 Sep; 14(9):88-92. PubMed ID: 15577118
[TBL] [Abstract][Full Text] [Related]
3. Four gland parathyroidectomy without reimplantation in patients with chronic renal failure.
Saunders RN; Karoo R; Metcalfe MS; Nicholson ML
Postgrad Med J; 2005 Apr; 81(954):255-8. PubMed ID: 15811891
[TBL] [Abstract][Full Text] [Related]
4. Parathyroid interventions for secondary hyperparathyroidism in hemodialyzed patients.
Onoda N; Kashiwagi T; Nakamura T; Niitsu Y; Omata M; Kurihara S
Ther Apher Dial; 2005 Aug; 9 Suppl 1():S11-5. PubMed ID: 16109135
[TBL] [Abstract][Full Text] [Related]
5. Parathyroidectomy as a therapeutic tool for targeting the recommended NKF-K/DOQI ranges for serum calcium, phosphate and parathyroid hormone in dialysis patients.
Mazzaferro S; Pasquali M; Farcomeni A; Vestri AR; Filippini A; Romani AM; Barresi G; Pugliese F
Nephrol Dial Transplant; 2008 Jul; 23(7):2319-23. PubMed ID: 18281320
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of percutaneous ethanol injection therapy for secondary hyperparathyroidism in patients on hemodialysis as evaluated by parathyroid hormone levels according to K/DOQI guidelines.
Tanaka M; Itoh K; Matsushita K; Matsushita K; Fukagawa M
Ther Apher Dial; 2005 Feb; 9(1):48-52. PubMed ID: 15828906
[TBL] [Abstract][Full Text] [Related]
7. Percutaneous ethanol injection therapy in post-transplant patients with secondary hyperparathyroidism.
Douthat WG; Orozco SE; Maino P; Cardozo G; de Arteaga J; de la Fuente J; Chiurchiu CR; Massari PU
Transpl Int; 2007 Dec; 20(12):1031-5. PubMed ID: 17883371
[TBL] [Abstract][Full Text] [Related]
8. Novel parathyroid hormone (1-84) assay as basis for parathyroid hormone monitoring in renal hyperparathyroidism.
Kaczirek K; Prager G; Riss P; Wunderer G; Asari R; Scheuba C; Bieglmayer C; Niederle B
Arch Surg; 2006 Feb; 141(2):129-34; discussion 134. PubMed ID: 16490888
[TBL] [Abstract][Full Text] [Related]
9. Improvement of anemia after parathyroidectomy in Chinese patients with renal failure undergoing long-term dialysis.
Chow TL; Chan TT; Ho YW; Lam SH
Arch Surg; 2007 Jul; 142(7):644-8. PubMed ID: 17638802
[TBL] [Abstract][Full Text] [Related]
10. Intra-operative parathyroid hormone monitoring in secondary hyperparathyroidism: is it useful?
Roshan A; Kamath B; Roberts S; Atkin SL; England RJ
Clin Otolaryngol; 2006 Jun; 31(3):198-203. PubMed ID: 16759239
[TBL] [Abstract][Full Text] [Related]
11. Prognosis of parathyroid function after successful percutaneous ethanol injection therapy guided by color Doppler flow mapping in chronic dialysis patients.
Kakuta T; Fukagawa M; Fujisaki T; Hida M; Suzuki H; Sakai H; Kurokawa K; Saito A
Am J Kidney Dis; 1999 Jun; 33(6):1091-9. PubMed ID: 10352197
[TBL] [Abstract][Full Text] [Related]
12. [A case of secondary hyperparathyroidism with an ectopic intrathyroid gland successfully diagnosed and controlled by percutaneous ethanol injection therapy (PEIT)].
Tanaka M; Itoh K; Matsushita K; Ogawa A; Hirayama H; Tsunoda N; Yoshizumi K; Naruse M; Nonoguchi H; Tomita K
Nihon Jinzo Gakkai Shi; 2002 May; 44(4):409-13. PubMed ID: 12073627
[TBL] [Abstract][Full Text] [Related]
13. [Medical-surgical integrated approach in the treatment of non-paraneoplasic hyperparathyroidism: our experience].
Pulvirenti D; Aikaterini T; Campagna A; Ignaccolo L; Giustolisi N; Costa E
Clin Ter; 2008; 159(5):307-10. PubMed ID: 18998031
[TBL] [Abstract][Full Text] [Related]
14. Relation of final intraoperative parathyroid hormone level and outcome following parathyroidectomy.
Heller KS; Blumberg SN
Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1103-7. PubMed ID: 19917922
[TBL] [Abstract][Full Text] [Related]
15. 1alpha(OH)D3 One-alpha-hydroxy-cholecalciferol--an active vitamin D analog. Clinical studies on prophylaxis and treatment of secondary hyperparathyroidism in uremic patients on chronic dialysis.
Brandi L
Dan Med Bull; 2008 Nov; 55(4):186-210. PubMed ID: 19232159
[TBL] [Abstract][Full Text] [Related]
16. Kidney Disease Improving Global Outcomes guidelines and parathyroidectomy for renal hyperparathyroidism.
Oltmann SC; Madkhali TM; Sippel RS; Chen H; Schneider DF
J Surg Res; 2015 Nov; 199(1):115-20. PubMed ID: 25982045
[TBL] [Abstract][Full Text] [Related]
17. Chemical ablation of recurrent and persistent secondary hyperparathyroidism after subtotal parathyroidectomy.
Chen HH; Lin CJ; Wu CJ; Lai CT; Lin J; Cheng SP; Yang TL
Ann Surg; 2011 Apr; 253(4):786-90. PubMed ID: 21475021
[TBL] [Abstract][Full Text] [Related]
18. Mysterious PTH values after parathyroidectomy in a patient on maintenance dialysis.
Thompson M; Schiller B
Hemodial Int; 2009 Oct; 13(4):543-6. PubMed ID: 19732173
[TBL] [Abstract][Full Text] [Related]
19. [Surgical treatment of secondary hyperparathyroidism in chronic renal failure. Report of 57 cases].
Sayad H; Jai SR; Ahazzam J; Lakhloufi A; Chihab F; Bouzidi A; Aghai R; Tarass F; Ramdani B; Hachim K; Benghanem NG; Zaid D
Tunis Med; 2008 Feb; 86(2):140-3. PubMed ID: 18444530
[TBL] [Abstract][Full Text] [Related]
20. Post-parathyroidectomy serum phosphate kinetics is peculiar to female hemodialysis patients with a high body mass index.
Lomonte C; Vernaglione L; Cazzato F; Casucci F; Chimienti D; Bruno A; Cocola S; Basile C
J Nephrol; 2006; 19(1):70-6. PubMed ID: 16523429
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
